AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

JUPITER GREEN INVESTMENT TRUST PLC

Declaration of Voting Results & Voting Rights Announcements Dec 31, 2019

4851_rns_2019-12-31_5f06fada-f288-4662-93f7-0a4091501b61.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4461Y

Jupiter Green Investment Trust Plc

31 December 2019

Jupiter Green Investment Trust PLC (the 'Company')

Legal Entity Identifier: 549300MFRCR13CT1L845
Total Voting Rights and Capital
In accordance with DTR 5.6.1 of the Financial Conduct Authority's Disclosure Guidance and Transparency Rules, the Company would like to notify the market of the following:

As at 31 December 2019, the Company's issued share capital consists of 33,724,958 Ordinary shares of 0.1p, carrying one vote each, of which 14,975,972 are held in treasury. Therefore as at 31 December 2019, the total number of voting rights in the Company is 18,748,986.
The above figure (18,748,986) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
For further information, please contact:

Magnus Spence

Head of Investment Trusts and Alternatives

Jupiter Asset Management Limited, Company Secretary

[email protected]

020 3817 1000

31 December 2019

www.jupiteram.com/JGC

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

TVREAAAFDDDNFFF

Talk to a Data Expert

Have a question? We'll get back to you promptly.